The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • 'cspec' property is found but contains no ID!

  • See Evidence submitted by expert panel for details.

Variant: NM_000545.8(HNF1A):c.494G>A (p.Trp165Ter)

CA386960529

447491 (ClinVar)

Gene: HNF1A
Condition: monogenic diabetes
Inheritance Mode: Autosomal dominant inheritance
UUID: 0cb0439e-cbf8-4132-9320-0f0e33231278

HGVS expressions

NM_000545.8:c.494G>A
NM_000545.8(HNF1A):c.494G>A (p.Trp165Ter)
NC_000012.12:g.120989000G>A
CM000674.2:g.120989000G>A
NC_000012.11:g.121426803G>A
CM000674.1:g.121426803G>A
NC_000012.10:g.119911186G>A
NG_011731.2:g.15255G>A
ENST00000257555.11:c.494G>A
ENST00000257555.10:c.494G>A
ENST00000400024.6:c.494G>A
ENST00000402929.5:n.629G>A
ENST00000535955.5:n.43-8491G>A
ENST00000538626.2:n.191-8491G>A
ENST00000538646.5:c.494G>A
ENST00000540108.1:c.327-4520G>A
ENST00000541395.5:c.494G>A
ENST00000541924.5:c.494G>A
ENST00000543427.5:c.494G>A
ENST00000544413.2:c.494G>A
ENST00000544574.5:c.73-7617G>A
ENST00000560968.5:n.637G>A
ENST00000615446.4:c.-257-7262G>A
ENST00000617366.4:c.494G>A
NM_000545.5:c.494G>A
NM_000545.6:c.494G>A
NM_001306179.1:c.494G>A
NM_001306179.2:c.494G>A

Pathogenic

Met criteria codes 4
PM2_Supporting PVS1 PP1_Moderate PP4
Not Met criteria codes 1
PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.494G>A variant in the HNF1 homeobox A gene, HNF1A, results in a premature termination at codon 165 (p.(Trp165Ter)) of NM_000545.8. This variant, located in biologically-relevant exon 2 of 10, is predicted to lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMID: 23348805). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). Furthermore, this variant segregated with diabetes, with three informative meioses, in one family with MODY (PP1_Moderate; internal lab contributors). This variant was identified in an individual with a clinical history suggestive of HNF1A-MODY (MODY probability estimated between 39-59% based on available clinical information, sulfonylurea-sensitive, and negative genetic testing for HNF4A) (PP4; internal lab contributors). In summary, c.494G>A meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/21): PVS1, PM2_Supporting, PP1_Moderate, PP4.
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD.
PVS1
A transcript with this variant is predicted to undergo nonsense mediated decay and this exon is present in a biologically relevant transcript.
PP1_Moderate
This variant segregated with disease in four informative meioses in one family with MODY (internal lab contributors).
PP4
This variant was identified in one individual with a clinical history suggestive of HNF1A-MODY (MODY probability calculator result at least 38.5%, negative genetic testing for HNF4A, and sulfonylurea-sensitive),
Not Met criteria codes
PS4
This variant was identified in two unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (internal lab contributors).
Approved on: 2022-06-10
Published on: 2022-06-10
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.